{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:37:26Z","timestamp":1785245846577,"version":"3.55.0"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>To diagnose Lyme neuroborreliosis (LNB), cerebrospinal fluid (CSF)\u00a0is tested for pleocytosis and intrathecal antibody production. The Dutch guideline for Lyme borreliosis indicates a lumbar puncture in the case of positive <jats:italic>Borrelia<\/jats:italic> serology or a strong clinical suspicion of LNB. This suggests that LNB might be underdiagnosed in patients with negative <jats:italic>Borrelia<\/jats:italic> serology and\/or a minor clinical suspicion. The objective was to assess how often negative <jats:italic>Borrelia<\/jats:italic> serology occurs in the case of LNB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A retrospective study was performed among patients with LNB visiting Gelre Hospitals between January 2007 and December 2020. Electronic medical records of patients with pleocytosis were reviewed to identify patients with LNB. Data were collected from medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Included were 127 patients with LNB, 58 of whom were children. In 67 patients <jats:italic>Borrelia<\/jats:italic> antibodies were present in both serum and CSF. In 53 of 67 patients there was intrathecal antibody production. In 28 patients there was intrathecal antibody production but serum antibodies were absent. Of patients with positive serology 77% had antibodies in CSF versus 83% of patients with negative serology (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.435). Of patients with positive serology 61% had intrathecal antibody production versus 78% of patients with negative serology (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.073).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Twenty\u2010eight LNB patients had intrathecal antibody production but no antibodies in serum. In this specific patient population, positive serum serology was not associated with antibodies in CSF nor with intrathecal antibody production. In Lyme endemic areas, in patients with symptoms suggestive for LNB, there is a need to lower the threshold for a lumbar puncture.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ene.15631","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T06:54:23Z","timestamp":1668322463000},"page":"741-744","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-4101","authenticated-orcid":false,"given":"Tizza P.","family":"Zomer","sequence":"first","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reitze","family":"Bruinsma","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"},{"name":"Department of Pediatrics Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"van Samkar","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"},{"name":"Department of Neurology Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande\u00a0M.","family":"Vermeeren","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"},{"name":"Department of Internal Medicine Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske G.","family":"Wieberdink","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"},{"name":"Department of Neurology Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend","family":"van Kooten","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"van Bemmel","sequence":"additional","affiliation":[{"name":"Lyme Centre Apeldoorn Gelre Hospital  Apeldoorn The Netherlands"},{"name":"Department of Internal Medicine Gelre Hospital  Apeldoorn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"Dutch National Guideline for Lyme Disease","author":"Dutch Quality Institute for Health Care (CBO)","year":"2013"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6221-8"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2112-z"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.03059.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1041"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00255-21"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3334-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1468-4"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000438"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ene.15631","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:49:57Z","timestamp":1692276597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.15631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1111\/ene.15631"],"URL":"https:\/\/doi.org\/10.1111\/ene.15631","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"2022-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}